Five developments I’m watching today: record investment into women’s health but a persistent Series A bottleneck, another USD 100 million flowing into AI-enabled drug discovery, an FDA rejection that shows why manufacturing is part of the biotech asset, menopause moving deeper into neurology, and healthcare continuing to outperform the broader market
Women’s Health Hits a Record as Healthcare Capital Gets More Selective
The Daily Capital Briefing — 11 August 2026
Keep reading with a 7-day free trial
Subscribe to The Billion Dollar Blindspot to keep reading this post and get 7 days of free access to the full post archives.